Ken Fisher Myriad Genetics Inc Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 905,209 shares of MYGN stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
905,209
Previous 602,842
50.16%
Holding current value
$10.5 Million
Previous $16.5 Million
24.78%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
92MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$175 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$122 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$69.4 Million0.02% of portfolio
-
State Street Corp Boston, MA5.53MShares$63.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$50.2 Million0.03% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $932M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...